NEUMORA THERAPEUTICS INC. - COMMON STOCK

Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

27 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

01 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Neumora Therapeutics to Participate in Upcoming Conferences in November

30 أكتوبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development

10 أكتوبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Neumora Therapeutics Announces Pricing of Initial Public Offering

14 سبتمبر 2023 20:49:04 بحسب Nasdaq GlobeNewswire